Nearly every newborn develops at least some degree of jaundice, the yellow tinting of the skin and eyes caused by a buildup of bilirubin in the blood. In most cases the yellowing is harmless and fades on its own within a week or two, but when bilirubin climbs too high or too fast, it can damage the brain. Understanding why newborns are so vulnerable to this pigment, what drives it beyond normal levels, and how clinicians bring it back down is more layered than the reassuring phrase “a little jaundice is normal” suggests.
Why Newborns Make So Much Bilirubin
Bilirubin is a byproduct of red blood cell breakdown. When old or damaged red cells are recycled, an enzyme called heme oxygenase converts the heme molecule into biliverdin, which is then quickly reduced to bilirubin. Newborns have far more of this enzyme activity than adults. In fetal rat liver, heme oxygenase runs at roughly twice the adult rate, and during the first postnatal week it climbs to about four times adult levels.1Pediatric Research. Enzymatic Conversion of Heme to Bilirubin in Normal and Starved Fetuses and Newborn Rats Babies also start life with a higher concentration of red blood cells than they will ever carry again, and those fetal red cells have shorter lifespans. The combination of more cells breaking down and a more active breakdown enzyme means newborns produce bilirubin at a pace their tiny livers struggle to match.
Once bilirubin is made, the liver must conjugate it, essentially attaching a sugar molecule so the compound becomes water-soluble and can be excreted in stool. Newborn livers have extremely low conjugating capacity.2PubMed Central. Fetal and neonatal bilirubin metabolism That enzyme system matures over the first few weeks of life, which is why jaundice in the first days is so common and why it usually resolves without intervention once the liver catches up. When something interferes with this balance, though, bilirubin can spike to dangerous levels.
Blood Group Incompatibility
The most common pathological cause of severe jaundice is a mismatch between the mother’s blood type and the baby’s. ABO incompatibility, where a mother with type O blood carries a baby with type A or B, is the classic scenario. The mother’s immune system produces antibodies that cross the placenta and attack the baby’s red blood cells, accelerating their destruction and flooding the system with bilirubin. In one large study, blood group incompatibility was present in over a third of jaundiced neonates, with ABO incompatibility alone accounting for about 29%.3PubMed. Hyperbilirubinemia in neonates with blood group incompatibilities – A bane or a boon for the management Less commonly, a non-O mother can produce antibodies against a baby with a different non-O type, though this scenario rarely causes severe disease.4PubMed Central. Hemolytic Disease of Newborn due to ABO Incompatibility between B Blood Group Mother and A Blood Group Neonate
Rh incompatibility, where an Rh-negative mother carries an Rh-positive baby, is less frequent today thanks to routine Rh immunoglobulin (RhoGAM) prophylaxis, but it still occurs and tends to cause more aggressive hemolysis than ABO mismatches. In the same study, Rh incompatibility accounted for about 5% of cases.3PubMed. Hyperbilirubinemia in neonates with blood group incompatibilities – A bane or a boon for the management When either type of incompatibility drives bilirubin high enough, exchange transfusion can effectively reduce levels in both ABO and Rh cases.5PubMed Central. A Comparative Analysis of the Efficacy of Blood Exchange Therapy in Neonatal Hyperbilirubinemia Induced by ABO and Rh Incompatibility
G6PD Deficiency and Genetic Susceptibility
Glucose-6-phosphate dehydrogenase deficiency is one of the most common inherited enzyme disorders worldwide, and in newborns it presents differently than the classic “favism” seen in older children and adults. Rather than dramatic hemolytic crises triggered by fava beans or certain drugs, G6PD-deficient neonates often show no obvious signs of rapid red cell destruction yet still develop dangerously high bilirubin levels.6PubMed Central. Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease Heterogeneity In a study of over 40,000 consecutive births, roughly 2.5% had G6PD deficiency, and about a quarter of those babies needed phototherapy.7Journal of Perinatology. Glucose-6-phosphate dehydrogenase deficiency and neonatal indirect hyperbilirubinemia: a retrospective cohort study among 40,305 consecutively born babies In populations where G6PD deficiency is more prevalent, the proportion of jaundiced newborns carrying the deficiency can be substantially higher.8Frontiers in Pediatrics. Etiology analysis and G6PD deficiency for term infants with jaundice in Yangjiang of western Guangdong
Beyond G6PD, genetic variation in the UGT1A1 gene, which encodes the liver enzyme responsible for conjugating bilirubin, plays a major role in how quickly a baby clears the pigment. Certain promoter polymorphisms are strongly linked to higher bilirubin levels. In one study of North Indian neonates, a variant UGT1A1 promoter was found in about 90% of babies with high bilirubin compared with 50% of controls, making it one of the strongest independent risk factors for severe jaundice alongside G6PD deficiency and a family history of neonatal jaundice.9Pediatric Research. UGT1A1 Gene Polymorphisms in North Indian Neonates Presenting with Unconjugated Hyperbilirubinemia Another variant, UGT1A1*6, common in East Asian populations, has been identified as the best predictor of prolonged severe jaundice, especially in exclusively breastfed infants.10Frontiers in Pediatrics. UGT1A1*6 mutation associated with the occurrence and severity in infants with prolonged jaundice The interaction of these genetic factors with environmental triggers like blood group incompatibility complicates the picture further, though the combined effect is not always simply additive.11PubMed. The role of UGT1A1 promoter polymorphism and exon-1 mutations in neonatal jaundice
Breastfeeding Jaundice and Breast Milk Jaundice
Two distinct forms of jaundice are linked to breastfeeding, and the names are confusingly similar. The first, often called breastfeeding jaundice, shows up in the first few days and is driven by insufficient milk intake. When a newborn is not getting enough calories, stool output drops, and bilirubin that would normally leave through the gut gets reabsorbed into the bloodstream instead. The fix is straightforward: more frequent feeding. The second, breast milk jaundice, appears later, typically after the first week, and is linked to one or more substances in the milk itself that slow bilirubin conjugation in the liver.12PubMed. Breastfeeding and breast milk jaundice Breast milk jaundice can linger for weeks but is almost always benign. Neither form should discourage breastfeeding, but the early-onset type is a signal that feeding support may be needed.
When Jaundice Signals Liver Disease
Almost all newborn jaundice involves unconjugated bilirubin, the form that has not yet been processed by the liver. But when jaundice includes a significant rise in conjugated (direct) bilirubin, that is a red flag for liver or bile-duct problems. Biliary atresia, a condition where the bile ducts outside the liver are blocked or absent, is a particularly time-sensitive diagnosis. At just 24 to 48 hours of life, babies who would later be diagnosed with biliary atresia already had conjugated bilirubin levels averaging around 1.4 mg/dL, compared with 0.19 mg/dL in controls, even while their total bilirubin remained unremarkable.13PubMed Central. Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth In otherwise healthy-appearing newborns with conjugated jaundice in the first two weeks, biliary atresia turned out to be the most common diagnosis, found in over 60% of a small series, and these babies initially had normal-colored stools and declining total bilirubin, making the condition easy to miss.14PubMed Central. Conjugated hyperbilirubinemia presenting in first fourteen days in term neonates That deceptive clinical picture is why guidelines stress checking the conjugated fraction when jaundice persists beyond two weeks or when stool becomes pale.
How Jaundice Is Detected and Measured
The classic visual clue is skin color, and jaundice follows a predictable pattern. It typically appears first on the face and spreads downward toward the trunk, limbs, and finally the palms and soles as bilirubin levels rise.15American Journal of Diseases of Children. Transcutaneous Bilirubinometry: The Cephalocaudal Progression of Dermal Icterus A nurse pressing gently on the baby’s skin and watching the blanched area turn yellow is still part of every newborn exam, but the human eye is a poor measuring instrument. Skin color, ambient lighting, and gestational age all distort visual assessment.16Acta Paediatrica. Assessment of jaundice in preterm neonates: comparison between clinical assessment, two transcutaneous bilirubinometers and serum bilirubin values
Handheld transcutaneous bilirubinometers, devices that bounce light off the skin and estimate bilirubin concentration, have become standard screening tools. A Cochrane review found that these devices have high sensitivity for ruling out significant jaundice, though a positive screen still requires a blood draw to confirm.17Cochrane Database of Systematic Reviews. Transcutaneous bilirubin measurement for detecting hyperbilirubinaemia in newborns Their accuracy is best before phototherapy has been started; once light treatment begins, bilirubin in the skin drops faster than bilirubin in the blood, and readings from uncovered skin become unreliable.18Pediatrics. Transcutaneous Bilirubin Accuracy Before, During, and After Phototherapy: A Meta-Analysis In preterm infants, sensitivity remains high at around 92%, but specificity drops, meaning more false positives and more blood draws.19PubMed Central. The Accuracy of Transcutaneous Bilirubin as a Screening Test in Preterm Infants
Complications of Untreated Severe Jaundice
Unconjugated bilirubin is fat-soluble, which means it can cross the blood-brain barrier and deposit in brain tissue. When it does, the results range from temporary distress to permanent devastation. Acute bilirubin encephalopathy typically progresses through phases: early on, the baby becomes lethargic with a weak cry and poor feeding; if bilirubin keeps rising, muscle tone abnormalities, fever, and a high-pitched cry develop; and in the most advanced stage, the baby may arch backward rigidly and become unresponsive.20PubMed. Characteristics and outcome of newborn admitted with acute bilirubin encephalopathy to a tertiary neonatal intensive care unit
If the acute injury is not reversed, it can evolve into chronic bilirubin encephalopathy, historically called kernicterus, a permanent condition defined by a cluster of four problems: abnormal movement and muscle tone, auditory processing difficulties or hearing loss, impairment of upward eye gaze, and enamel defects in the baby teeth.21PubMed. Chronic bilirubin encephalopathy: diagnosis and outcome Hearing loss is one of the earliest and most sensitive markers of bilirubin toxicity. Among jaundiced babies with sensorineural hearing loss, abnormal eye movements, backward arching, and small head circumference were all significantly more common than in jaundiced babies with normal hearing.22PubMed Central. Risk Factors for Sensorineural Hearing Loss in Neonatal Hyperbilirubinemia Even among babies who avoid the full kernicterus picture, auditory and developmental problems can show up later. In one follow-up study, roughly 10% of children with a history of significant jaundice had hearing problems, and about 12% showed abnormal developmental screening results.23PubMed Central. Long-term Effects of Indirect Hyperbilirubinemia on Auditory and Neurological Functions in Term Newborns
Phototherapy
Light is the first-line treatment for newborns whose bilirubin is climbing too fast or too high. Phototherapy works by shining blue-to-green light (in the 460–490 nanometer range) onto the baby’s skin, where it converts bilirubin into water-soluble forms the body can excrete without waiting for the liver to conjugate them. The American Academy of Pediatrics recommends an irradiance of at least 30 μW·cm⁻²·nm⁻¹ for intensive phototherapy, with the light covering as much of the baby’s body surface as possible.24Pediatrics. Phototherapy to Prevent Severe Neonatal Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation A measurable drop in total bilirubin within the first four to six hours of exposure is considered a sign that the device is working effectively.
Phototherapy is widely considered safe, but it is not without concerns. Research has raised questions about potential short- and long-term effects, including a possible association with allergic diseases, DNA damage, and rare cases of hemolysis in the treated baby.25PubMed Central. Challenges of phototherapy for neonatal hyperbilirubinemia The clinical consensus remains that the risk-benefit balance strongly favors phototherapy when bilirubin is at treatment thresholds, but the findings reinforce that light treatment should not be used casually when bilirubin is well below intervention levels.
Exchange Transfusion
When phototherapy fails to control bilirubin or when levels are already dangerously high at presentation, exchange transfusion becomes necessary. The procedure removes the baby’s blood in small increments and replaces it with donor blood, physically washing out bilirubin along with the antibodies driving hemolysis in cases of blood group incompatibility. A double-volume exchange replaces roughly twice the baby’s blood volume and can remove a large fraction of circulating bilirubin in a single session.
Exchange transfusion is effective but carries real risks. In one review of nearly 400 newborns who underwent the procedure, no deaths occurred, and most babies needed only a single treatment.26PubMed Central. Exchange Transfusion for Severe Neonatal Hyperbilirubinemia: 17 Years’ Experience from Vojvodina, Serbia Other centers have reported less favorable numbers. A five-year series found complications in about 39% of treated babies, with low platelet counts and low calcium levels being the most frequent problems, and one death among the 148 patients.27Journal of Comprehensive Pediatrics. Complications of Exchange Transfusion in Hospitalized Neonates in Two Neonatal Centers in Hamadan, A Five-Year Experience The risk is substantially higher for babies who are already sick with other medical conditions. In a study separating healthy from ill infants, none of the 81 healthy babies died, but among the 25 who were already ill, at least three experienced severe complications including two deaths.28PubMed. Adverse events associated with exchange transfusion in healthy and ill newborns That disparity matters for clinical decision-making: in a sick infant, the threshold for exchange transfusion has to be weighed against a meaningful procedural risk.
Filtered Sunlight in Low-Resource Settings
Conventional phototherapy requires reliable electricity and a steady supply of functioning light devices, both of which are scarce in many parts of the world where severe jaundice is most common. A creative alternative is filtered-sunlight phototherapy, which passes natural sunlight through special window tinting films that block ultraviolet radiation and reduce infrared heat while preserving the therapeutic blue wavelengths. In a randomized trial in Nigeria, filtered sunlight was effective on 93% of evaluable treatment days, compared with 90% for conventional phototherapy, and actually delivered higher irradiance on average.29PubMed. A Randomized Trial of Phototherapy with Filtered Sunlight in African Neonates No baby required withdrawal for safety reasons, though mild overheating was more common in the sunlight group.
Subsequent research has extended these findings to babies with moderate-to-severe jaundice, confirming that filtered sunlight is safe and non-inferior to electric phototherapy in this sicker group as well.30PubMed. Filtered-sunlight phototherapy for newborns with moderate-to-severe hyperbilirubinemia: a randomized trial A broader evidence synthesis concluded that this approach works for any degree of jaundice, with rates of exchange transfusion and mortality comparable to conventional treatment.31PubMed Central. Filtered-sunlight phototherapy for neonatal jaundice in low-resource settings: evidence for action In settings where the choice is between filtered sunlight and no phototherapy at all, the approach is potentially life-saving.
Bilirubin as an Antioxidant
There is an ironic twist to the bilirubin story: the same molecule that can destroy brain cells is also a potent antioxidant. At the low concentrations found in adult blood, bilirubin scavenges reactive oxygen species and protects cells from oxidative damage. Accumulating evidence links mildly elevated bilirubin in adults with lower rates of cardiovascular disease and other conditions, and genetic variants that nudge bilirubin slightly higher appear to confer a protective advantage.32PubMed. Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia In newborns, the heme oxygenase pathway that generates bilirubin also produces carbon monoxide, which itself has anti-inflammatory properties.33PubMed Central. Two Faces of Heme Catabolic Pathway in Newborns: A Potential Role of Bilirubin and Carbon Monoxide in Neonatal Inflammatory Diseases This dual nature of bilirubin, toxic at high doses but protective at moderate ones, is one reason the body never evolved to eliminate it entirely. For newborns, though, the protection is beside the point when levels shoot into the danger zone.
Parental Anxiety and the Hospital Experience
For parents, the experience of watching their newborn lie under bright lights, sometimes with eyes covered and separated from skin-to-skin contact, can be deeply distressing. A validated anxiety scale developed specifically for this situation found that maternal anxiety among mothers of jaundiced newborns is widespread, with the average mother scoring near the midpoint of a scale that ranges from minimal to high worry.34PubMed Central. Development and validation of a maternal anxiety for neonatal jaundice scale in China Part of this anxiety may stem from the gap between how casually some providers discuss jaundice and how alarming it is to see your baby under treatment. Clear communication about what phototherapy does, why the baby needs it, and when it will likely end goes a long way. So does allowing breastfeeding breaks during treatment, which most current guidelines endorse unless bilirubin is in the critical range.
The emotional toll is worth acknowledging because it can influence feeding decisions. Some parents, hearing that breastfeeding is associated with jaundice, may feel pressure to switch to formula. Understanding the distinction between early breastfeeding jaundice, which is solved by more breastfeeding rather than less, and the generally harmless later-onset breast milk jaundice can keep families from abandoning breastfeeding unnecessarily.